Kimberly P. Dunsmore

5.7k total citations
43 papers, 936 citations indexed

About

Kimberly P. Dunsmore is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Kimberly P. Dunsmore has authored 43 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Public Health, Environmental and Occupational Health, 17 papers in Pediatrics, Perinatology and Child Health and 14 papers in Hematology. Recurrent topics in Kimberly P. Dunsmore's work include Acute Lymphoblastic Leukemia research (32 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Lymphoma Diagnosis and Treatment (10 papers). Kimberly P. Dunsmore is often cited by papers focused on Acute Lymphoblastic Leukemia research (32 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Lymphoma Diagnosis and Treatment (10 papers). Kimberly P. Dunsmore collaborates with scholars based in United States, Canada and Australia. Kimberly P. Dunsmore's co-authors include Stuart S. Winter, Brent L. Wood, Mignon L. Loh, Stephen P. Hunger, Meenakshi Devidas, William L. Carroll, Naomi Winick, Elizabeth A. Raetz, Jonathan R. Fromm and Harvey A. Greisman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

Kimberly P. Dunsmore

42 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly P. Dunsmore United States 15 552 393 299 210 168 43 936
Udo zur Stadt Germany 14 663 1.2× 641 1.6× 255 0.9× 240 1.1× 242 1.4× 37 1.2k
Barbara Buldini Italy 19 630 1.1× 671 1.7× 219 0.7× 196 0.9× 159 0.9× 56 1.2k
MJ Willemse Netherlands 13 569 1.0× 490 1.2× 169 0.6× 100 0.5× 225 1.3× 13 805
Nicholas J. Goulden United Kingdom 11 450 0.8× 531 1.4× 136 0.5× 196 0.9× 49 0.3× 23 826
DR Head United States 9 514 0.9× 519 1.3× 104 0.3× 168 0.8× 191 1.1× 14 890
ME Trigg United States 12 676 1.2× 636 1.6× 386 1.3× 199 0.9× 62 0.4× 21 1.0k
Anja Moericke Germany 12 451 0.8× 312 0.8× 224 0.7× 83 0.4× 81 0.5× 24 618
MF Greaves United Kingdom 8 386 0.7× 279 0.7× 179 0.6× 176 0.8× 92 0.5× 11 856
GR Buchanan United States 12 373 0.7× 410 1.0× 161 0.5× 80 0.4× 64 0.4× 15 710
SJ Forman United States 16 401 0.7× 621 1.6× 86 0.3× 252 1.2× 196 1.2× 31 1.1k

Countries citing papers authored by Kimberly P. Dunsmore

Since Specialization
Citations

This map shows the geographic impact of Kimberly P. Dunsmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly P. Dunsmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly P. Dunsmore more than expected).

Fields of papers citing papers by Kimberly P. Dunsmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly P. Dunsmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly P. Dunsmore. The network helps show where Kimberly P. Dunsmore may publish in the future.

Co-authorship network of co-authors of Kimberly P. Dunsmore

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly P. Dunsmore. A scholar is included among the top collaborators of Kimberly P. Dunsmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly P. Dunsmore. Kimberly P. Dunsmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gossai, Nathan, Meenakshi Devidas, Zhiguo Chen, et al.. (2023). Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report. Blood. 141(15). 1802–1811. 14 indexed citations
2.
Xu, Xinjie, Christian N. Paxton, Robert J. Hayashi, et al.. (2021). Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Blood Advances. 5(14). 2890–2900. 5 indexed citations
3.
Hayashi, Robert J., Stuart S. Winter, Kimberly P. Dunsmore, et al.. (2020). Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children’s Oncology Group AALL0434. Journal of Clinical Oncology. 38(26). 3062–3070. 38 indexed citations
4.
Kang, Huining, Nitesh Sharma, Christian K. Nickl, et al.. (2018). Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL. Biomarker Research. 6(1). 27–27. 9 indexed citations
5.
Gupta, Sumit, Meenakshi Devidas, Mignon L. Loh, et al.. (2018). Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG). Leukemia. 32(6). 1370–1379. 32 indexed citations
6.
Hayashi, Robert J., Stuart S. Winter, Kimberly P. Dunsmore, et al.. (2018). Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL). Blood. 132(Supplement 1). 1000–1000. 2 indexed citations
7.
Burns, Melissa, Gayle P. Pouliot, Kristen E. Stevenson, et al.. (2018). Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia. Leukemia. 32(10). 2126–2137. 44 indexed citations
8.
Winter, Stuart S., Kimberly P. Dunsmore, Meenakshi Devidas, et al.. (2015). Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T‐cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. Pediatric Blood & Cancer. 62(7). 1176–1183. 56 indexed citations
9.
10.
Dunsmore, Kimberly P., Meenakshi Devidas, Stephen B. Linda, et al.. (2012). Pilot Study of Nelarabine in Combination With Intensive Chemotherapy in High-Risk T-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(22). 2753–2759. 59 indexed citations
11.
12.
Winter, Stuart S., Meenakshi Devidas, Brent L. Wood, et al.. (2010). Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. Blood. 116(21). 865–865. 2 indexed citations
13.
Roshal, Mikhail, Jonathan R. Fromm, Stuart S. Winter, Kimberly P. Dunsmore, & Brent L. Wood. (2010). Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detection. Cytometry Part B Clinical Cytometry. 78B(3). 139–146. 52 indexed citations
14.
15.
Dunsmore, Kimberly P. & Mark A. Lovell. (1998). Small Bowel Adenocarcinoma Metastatic to the Ovaries in a 12-Year-Old Girl. Journal of Pediatric Hematology/Oncology. 20(5). 498–501. 3 indexed citations
16.
Dunsmore, Kimberly P.. (1997). Intravenous Immunoglobulin G Therapy in Fetal and Neonatal Alloimmune Thrombocytopenia. BioDrugs. 8(4). 265–272. 3 indexed citations
17.
Dunsmore, Kimberly P., Henry S. Friedman, & Joanne Kurtzberg. (1992). The uses of intravenous immunoglobulin in pediatrics. Critical Reviews in Oncology/Hematology. 12(2). 67–90. 1 indexed citations
18.
Dunsmore, Kimberly P., et al.. (1992). IVIG therapy in neonatal isoimmune thrombocytopenic purpura and alloimmunization thrombocytopenia. Clinical Reviews in Allergy. 10(1-2). 73–80. 1 indexed citations
19.
Kurtzberg, Joanne & Kimberly P. Dunsmore. (1992). IVIG Therapy in Neonatal Isoimmune Thrombocytopenic Purpura and Alloimmunization Thrombocytopenia. Humana Press eBooks. 10(1-2). 73–80. 1 indexed citations
20.
Becker, Jeffrey M., et al.. (1982). Photoinactivation of peptide transport in Saccharomyces cerevisiae. Biochemistry. 21(23). 5967–5971. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Udo zur Stadt Breakdown of academic impact, for papers by Barbara Buldini Breakdown of academic impact, for papers by MJ Willemse Breakdown of academic impact, for papers by Nicholas J. Goulden Breakdown of academic impact, for papers by DR Head Breakdown of academic impact, for papers by ME Trigg Breakdown of academic impact, for papers by Anja Moericke Breakdown of academic impact, for papers by MF Greaves Breakdown of academic impact, for papers by GR Buchanan Breakdown of academic impact, for papers by SJ Forman
Rankless by CCL
2026